Gout
📧 Sign up to get email alerts when something new happens for Gout.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2015-05-13FDA Approved: ALOPRIM — Supplemental Application (Mylan Institutional LLC)
The FDA approved a supplemental application for ALOPRIM (allopurinol) submitted by Mylan Institutional LLC, resulting in updated labeling.
-
CLINICAL_TRIALS trial_result · 2015-04-17Clinical Trial Update: Safety and Efficacy Study of MBX-102 in Treatment of Hyperuricemia in Patients With Gout [Phase 2]
Phase 2 trial update reporting safety and efficacy findings for MBX-102 in treating hyperuricemia in patients with gout.
-
CLINICAL_TRIALS trial_result · 2015-04-17Clinical Trial Update: Evaluate the PK, PD, and Safety of Arhalofenate in Combination With Febuxostat for Hyperuricemia in Patients With Gout [Phase 2]
Phase 2 trial update reporting pharmacokinetics, pharmacodynamics, and safety of combining arhalofenate with febuxostat in patients with gou…
-
CLINICAL_TRIALS trial_result · 2015-04-03Clinical Trial Update: Open Label Safety/Efficacy Study of Arhalofenate in Combination With Febuxostat for Hyperuricemia in Gout Patients [Phase 2]
Open-label Phase 2 safety and efficacy study of combining arhalofenate with febuxostat for hyperuricemia and gout has completed.
-
CLINICAL_TRIALS trial_result · 2015-03-24Clinical Trial Update: Effect of Quercetin Supplements on Healthy Males: a Four-Week Randomized Cross-Over Trial [EARLY_Phase 1]
A four-week randomized cross-over Phase 1 trial evaluated the effects of quercetin supplements in healthy male participants and has complete…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-03-06Clinical Trial Update: Evaluating the Effectiveness of a Chronic Disease Management Program for Gout [NA]
A completed Kaiser Permanente study evaluated the effectiveness of a chronic disease management program for gout. The trial targeted individ…
-
CLINICAL_TRIALS trial_result · 2015-01-26Clinical Trial Update: Study of FYU-981 in Hyperuricemia With or Without Gout [Phase 2]
Phase 2 clinical trial evaluating FYU-981 for hyperuricemia with or without gout has completed.
-
CLINICAL_TRIALS trial_result · 2015-01-05Clinical Trial Update: Does Allopurinol Prolong a Treated, Acute Gout Flare? [Phase 4]
Phase 4 trial evaluating whether allopurinol prolongs a treated, acute gout flare; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2014-12-01Clinical Trial Update: A Proof-of-Concept Study of AC-201 to Prevent Gout Flares [Phase 2]
A Phase 2 proof-of-concept trial of AC-201 to prevent gout flares has completed, with results posted in 2014.
-
FDA approval · 2014-11-02FDA Approved: NAPROXEN — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for Naproxen by Amneal Pharmaceuticals of New York LLC (generic Naproxen).
-
CLINICAL_TRIALS trial_result · 2014-10-29Clinical Trial Update: A Study to Evaluate Safety and Efficacy of Oral Febuxostat in Patients With Gout [Phase 3]
This clinical trial update reports that a Phase 3 study evaluating the safety and efficacy of oral febuxostat in gout has completed.
-
FDA approval · 2014-10-16FDA Approved: INDOCIN — Supplemental Application (Zyla Life Sciences US LLC)
FDA approved a supplemental application for Indocin (indomethacin) submitted by Zyla Life Sciences US LLC.
-
FDA approval · 2014-09-26FDA Approved: MITIGARE — Original Application (Hikma Specialty USA Inc.)
FDA approved the Mitigare brand of colchicine (Hikma Specialty USA Inc.) through an Original Application. This establishes a labeled colchic…
-
CLINICAL_TRIALS trial_result · 2014-09-10Clinical Trial Update: Effect of Febuxostat on Joint Damage in Hyperuricemic Subjects With Early Gout [Phase 2]
Phase 2 trial update assessing the effect of febuxostat on joint damage in hyperuricemic subjects with early gout; results were posted in 20…
-
CLINICAL_TRIALS research · 2014-09-03Clinical Trial Update: Rheumatology Informatics System for Effectiveness
This document provides an update on the Rheumatology Informatics System for Effectiveness, a clinical trial evaluating an informatics platfo…
-
FDA approval · 2014-08-14FDA Approved: COLCRYS — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approves a supplemental application for COLCRYS (colchicine) submitted by Takeda Pharmaceuticals America, Inc. The supplemental approval…
-
CLINICAL_TRIALS trial_result · 2014-07-28Clinical Trial Update: Safety/Efficacy Study to Evaluate of MBX-102 in Combination With Allopurinol in Gout Patients [Phase 2]
Phase 2 clinical trial evaluating MBX-102 in combination with allopurinol for gout. The study is completed and results were posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-06-17Clinical Trial Update: Allopurinol Outcome Study [Phase 4]
Phase 4 outcome study of allopurinol for gout completed with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-05-30Clinical Trial Update: Apolipoprotein CIII Reduction Via Colchicine [EARLY_Phase 1]
An early-phase trial completed evaluating colchicine as a strategy to reduce apolipoprotein CIII in hypertriglyceridemia. The study also rel…
-
CLINICAL_TRIALS trial_result · 2014-05-12Clinical Trial Update: Efficacy and Safety of Colchicine for the Prevention of Gout Flares During the Initiation of Allopurinol [Phase 4]
Phase 4 trial evaluating whether colchicine prevents gout flares during initiation of allopurinol, reporting efficacy and safety results.
-
CLINICAL_TRIALS trial_result · 2014-05-08Clinical Trial Update: Immune Molecular and Inflammatory Cytokines Dysfunction Analysis in Gout Patients With Different Urate Levels [Phase 4]
Phase 4 clinical trial update examining immune molecular and inflammatory cytokines dysfunction in gout patients across different urate leve…
-
CLINICAL_TRIALS research · 2014-04-14Clinical Trial Update: The Influence of Antiphospholipid Antibodies on the Relationship Between Hyperurecemia, Gout and Metabolic Syndrome
A clinical trial update investigating whether antiphospholipid antibodies affect the relationship between hyperuricemia, gout, and metabolic…
-
CLINICAL_TRIALS trial_result · 2014-03-07Clinical Trial Update: Gout Dose Response Study [Phase 2]
Phase II gout dose-response trial completed; the study sponsored by Ardea Biosciences focused on hyperuricemia.
-
CLINICAL_TRIALS trial_result · 2014-02-06Clinical Trial Update: A Study of RDEA806 in Hyperuricemic Subjects With Symptomatic Gout [Phase 2]
Phase 2 clinical trial evaluating RDEA806 in hyperuricemic subjects with symptomatic gout has completed.
-
CLINICAL_TRIALS trial_result · 2014-01-29Clinical Trial Update: Safety and Efficacy of Canakinumab Prefilled Syringes in Frequently Flaring Acute Gouty Arthritis Patients [Phase 3]
Phase 3 trial results evaluate the safety and efficacy of canakinumab prefilled syringes in patients with frequently flaring acute gouty art…